HighCape Capital Acquisition Corp. II (HCCR)
| Market Cap | 256.00M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 25.60M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | n/a |
| Last Price | n/a |
| Previous Close | n/a |
| Change ($) | n/a |
| Change (%) | n/a |
| Day's Open | n/a |
| Day's Range | n/a |
| Day's Volume | n/a |
| 52-Week Range | n/a |
HighCape Capital Acquisition II, the second blank check company formed by HighCape Capital targeting life sciences, filed on Wednesday with the SEC to raise up to $200 million in an initial public offer...
HighCape Capital Acquisition Corp. II has filed to go public with an IPO on the NASDAQ.
About HCCR
HighCape Capital Acquisition II is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to focus on industries that complement our management team’s background in life sciences and life sciences related industries, and to capitalize on the ability of our management team to identify and acquire a business within those industries. We intend to focus our investment effort ... [Read more...]
| Industry Blank Checks / SPAC | IPO Date Pending |
| CEO Kevin Rakin | Country United States |
| Stock Exchange NASDAQ | Ticker Symbol HCCR |